Genetics of Parkinson's disease and parkinsonism
Identifieur interne : 001D61 ( Main/Corpus ); précédent : 001D60; suivant : 001D62Genetics of Parkinson's disease and parkinsonism
Auteurs : John Hardy ; Huaiban Cai ; Mark R. Cookson ; Katrina Gwinn-Hardy ; Andrew SingletonSource :
- Annals of Neurology [ 0364-5134 ] ; 2006-10.
Abstract
Until 10 years ago, conventional wisdom held that Parkinson's disease was not a genetic disorder. Since that time, there have been a plethora of genetic findings, culminating in the cloning of several genes that derive from the loci given the nomenclature PARK1‐PARK12 (OMIM 168600). Recently, these research findings have begun to impact clinical practice, and this impact is likely to increase. The primary purpose of this article is to outline these genetic advances, discuss their importance for current practice in clinical and related settings, and outline briefly how they are influencing research into the causes of and possible future treatments for this prevalent disorder. Ann Neurol 2006;60:389–398
Url:
DOI: 10.1002/ana.21022
Links to Exploration step
ISTEX:6FDB66D127E121559A4DA0D9AB3ACBE00279F873Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Genetics of Parkinson's disease and parkinsonism</title><author><name sortKey="Hardy, John" sort="Hardy, John" uniqKey="Hardy J" first="John" last="Hardy">John Hardy</name><affiliation><mods:affiliation>Laboratory of Neurogenetics, National Institute on Aging, National Institutes on Health, Bethesda, MD</mods:affiliation></affiliation></author><author><name sortKey="Cai, Huaiban" sort="Cai, Huaiban" uniqKey="Cai H" first="Huaiban" last="Cai">Huaiban Cai</name><affiliation><mods:affiliation>Laboratory of Neurogenetics, National Institute on Aging, National Institutes on Health, Bethesda, MD</mods:affiliation></affiliation></author><author><name sortKey="Cookson, Mark R" sort="Cookson, Mark R" uniqKey="Cookson M" first="Mark R." last="Cookson">Mark R. Cookson</name><affiliation><mods:affiliation>Laboratory of Neurogenetics, National Institute on Aging, National Institutes on Health, Bethesda, MD</mods:affiliation></affiliation></author><author><name sortKey="Gwinn Ardy, Katrina" sort="Gwinn Ardy, Katrina" uniqKey="Gwinn Ardy K" first="Katrina" last="Gwinn-Hardy">Katrina Gwinn-Hardy</name><affiliation><mods:affiliation>National Institute of Neurological Diseases and Stroke, National Institutes of Health, Bethesda, MD</mods:affiliation></affiliation></author><author><name sortKey="Singleton, Andrew" sort="Singleton, Andrew" uniqKey="Singleton A" first="Andrew" last="Singleton">Andrew Singleton</name><affiliation><mods:affiliation>Laboratory of Neurogenetics, National Institute on Aging, National Institutes on Health, Bethesda, MD</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:6FDB66D127E121559A4DA0D9AB3ACBE00279F873</idno><date when="2006" year="2006">2006</date><idno type="doi">10.1002/ana.21022</idno><idno type="url">https://api.istex.fr/document/6FDB66D127E121559A4DA0D9AB3ACBE00279F873/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">001D61</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Genetics of Parkinson's disease and parkinsonism</title><author><name sortKey="Hardy, John" sort="Hardy, John" uniqKey="Hardy J" first="John" last="Hardy">John Hardy</name><affiliation><mods:affiliation>Laboratory of Neurogenetics, National Institute on Aging, National Institutes on Health, Bethesda, MD</mods:affiliation></affiliation></author><author><name sortKey="Cai, Huaiban" sort="Cai, Huaiban" uniqKey="Cai H" first="Huaiban" last="Cai">Huaiban Cai</name><affiliation><mods:affiliation>Laboratory of Neurogenetics, National Institute on Aging, National Institutes on Health, Bethesda, MD</mods:affiliation></affiliation></author><author><name sortKey="Cookson, Mark R" sort="Cookson, Mark R" uniqKey="Cookson M" first="Mark R." last="Cookson">Mark R. Cookson</name><affiliation><mods:affiliation>Laboratory of Neurogenetics, National Institute on Aging, National Institutes on Health, Bethesda, MD</mods:affiliation></affiliation></author><author><name sortKey="Gwinn Ardy, Katrina" sort="Gwinn Ardy, Katrina" uniqKey="Gwinn Ardy K" first="Katrina" last="Gwinn-Hardy">Katrina Gwinn-Hardy</name><affiliation><mods:affiliation>National Institute of Neurological Diseases and Stroke, National Institutes of Health, Bethesda, MD</mods:affiliation></affiliation></author><author><name sortKey="Singleton, Andrew" sort="Singleton, Andrew" uniqKey="Singleton A" first="Andrew" last="Singleton">Andrew Singleton</name><affiliation><mods:affiliation>Laboratory of Neurogenetics, National Institute on Aging, National Institutes on Health, Bethesda, MD</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Annals of Neurology</title><title level="j" type="abbrev">Ann Neurol.</title><idno type="ISSN">0364-5134</idno><idno type="eISSN">1531-8249</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2006-10">2006-10</date><biblScope unit="volume">60</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="page" from="389">389</biblScope><biblScope unit="page" to="398">398</biblScope></imprint><idno type="ISSN">0364-5134</idno></series><idno type="istex">6FDB66D127E121559A4DA0D9AB3ACBE00279F873</idno><idno type="DOI">10.1002/ana.21022</idno><idno type="ArticleID">ANA21022</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0364-5134</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Until 10 years ago, conventional wisdom held that Parkinson's disease was not a genetic disorder. Since that time, there have been a plethora of genetic findings, culminating in the cloning of several genes that derive from the loci given the nomenclature PARK1‐PARK12 (OMIM 168600). Recently, these research findings have begun to impact clinical practice, and this impact is likely to increase. The primary purpose of this article is to outline these genetic advances, discuss their importance for current practice in clinical and related settings, and outline briefly how they are influencing research into the causes of and possible future treatments for this prevalent disorder. Ann Neurol 2006;60:389–398</div></front></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>John Hardy PhD</name><affiliations><json:string>Laboratory of Neurogenetics, National Institute on Aging, National Institutes on Health, Bethesda, MD</json:string></affiliations></json:item><json:item><name>Huaiban Cai PhD</name><affiliations><json:string>Laboratory of Neurogenetics, National Institute on Aging, National Institutes on Health, Bethesda, MD</json:string></affiliations></json:item><json:item><name>Mark R. Cookson PhD</name><affiliations><json:string>Laboratory of Neurogenetics, National Institute on Aging, National Institutes on Health, Bethesda, MD</json:string></affiliations></json:item><json:item><name>Katrina Gwinn‐Hardy MD</name><affiliations><json:string>National Institute of Neurological Diseases and Stroke, National Institutes of Health, Bethesda, MD</json:string></affiliations></json:item><json:item><name>Andrew Singleton PhD</name><affiliations><json:string>Laboratory of Neurogenetics, National Institute on Aging, National Institutes on Health, Bethesda, MD</json:string></affiliations></json:item></author><articleId><json:string>ANA21022</json:string></articleId><language><json:string>eng</json:string></language><abstract>Until 10 years ago, conventional wisdom held that Parkinson's disease was not a genetic disorder. Since that time, there have been a plethora of genetic findings, culminating in the cloning of several genes that derive from the loci given the nomenclature PARK1‐PARK12 (OMIM 168600). Recently, these research findings have begun to impact clinical practice, and this impact is likely to increase. The primary purpose of this article is to outline these genetic advances, discuss their importance for current practice in clinical and related settings, and outline briefly how they are influencing research into the causes of and possible future treatments for this prevalent disorder. Ann Neurol 2006;60:389–398</abstract><qualityIndicators><score>6.284</score><pdfVersion>1.3</pdfVersion><pdfPageSize>594 x 783 pts</pdfPageSize><refBibsNative>true</refBibsNative><keywordCount>0</keywordCount><abstractCharCount>710</abstractCharCount><pdfWordCount>7735</pdfWordCount><pdfCharCount>47780</pdfCharCount><pdfPageCount>10</pdfPageCount><abstractWordCount>107</abstractWordCount></qualityIndicators><title>Genetics of Parkinson's disease and parkinsonism</title><genre><json:string>other</json:string></genre><host><volume>60</volume><publisherId><json:string>ANA</json:string></publisherId><pages><total>10</total><last>398</last><first>389</first></pages><issn><json:string>0364-5134</json:string></issn><issue>4</issue><subject><json:item><value>Neurological Progress</value></json:item></subject><genre><json:string>Journal</json:string></genre><language><json:string>unknown</json:string></language><eissn><json:string>1531-8249</json:string></eissn><title>Annals of Neurology</title><doi><json:string>10.1002/(ISSN)1531-8249</json:string></doi></host><publicationDate>2006</publicationDate><copyrightDate>2006</copyrightDate><doi><json:string>10.1002/ana.21022</json:string></doi><id>6FDB66D127E121559A4DA0D9AB3ACBE00279F873</id><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/6FDB66D127E121559A4DA0D9AB3ACBE00279F873/fulltext/pdf</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/6FDB66D127E121559A4DA0D9AB3ACBE00279F873/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/6FDB66D127E121559A4DA0D9AB3ACBE00279F873/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Genetics of Parkinson's disease and parkinsonism</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><availability><p>WILEY</p></availability><date>2006</date></publicationStmt><notesStmt><note>Intramural Research Program of the NIH (National Institute on Aging)</note></notesStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Genetics of Parkinson's disease and parkinsonism</title><author><persName><forename type="first">John</forename><surname>Hardy</surname></persName><roleName type="degree">PhD</roleName><note type="correspondence"><p>Correspondence: Laboratory of Neurogenetics, National Institute on Aging, Porter Neuroscience Building, 35 Convent Drive, Bethesda, MD 20892</p></note><affiliation>Laboratory of Neurogenetics, National Institute on Aging, National Institutes on Health, Bethesda, MD</affiliation></author><author><persName><forename type="first">Huaiban</forename><surname>Cai</surname></persName><roleName type="degree">PhD</roleName><affiliation>Laboratory of Neurogenetics, National Institute on Aging, National Institutes on Health, Bethesda, MD</affiliation></author><author><persName><forename type="first">Mark R.</forename><surname>Cookson</surname></persName><roleName type="degree">PhD</roleName><affiliation>Laboratory of Neurogenetics, National Institute on Aging, National Institutes on Health, Bethesda, MD</affiliation></author><author><persName><forename type="first">Katrina</forename><surname>Gwinn‐Hardy</surname></persName><roleName type="degree">MD</roleName><affiliation>National Institute of Neurological Diseases and Stroke, National Institutes of Health, Bethesda, MD</affiliation></author><author><persName><forename type="first">Andrew</forename><surname>Singleton</surname></persName><roleName type="degree">PhD</roleName><affiliation>Laboratory of Neurogenetics, National Institute on Aging, National Institutes on Health, Bethesda, MD</affiliation></author></analytic><monogr><title level="j">Annals of Neurology</title><title level="j" type="abbrev">Ann Neurol.</title><idno type="pISSN">0364-5134</idno><idno type="eISSN">1531-8249</idno><idno type="DOI">10.1002/(ISSN)1531-8249</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2006-10"></date><biblScope unit="volume">60</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="page" from="389">389</biblScope><biblScope unit="page" to="398">398</biblScope></imprint></monogr><idno type="istex">6FDB66D127E121559A4DA0D9AB3ACBE00279F873</idno><idno type="DOI">10.1002/ana.21022</idno><idno type="ArticleID">ANA21022</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2006</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>Until 10 years ago, conventional wisdom held that Parkinson's disease was not a genetic disorder. Since that time, there have been a plethora of genetic findings, culminating in the cloning of several genes that derive from the loci given the nomenclature PARK1‐PARK12 (OMIM 168600). Recently, these research findings have begun to impact clinical practice, and this impact is likely to increase. The primary purpose of this article is to outline these genetic advances, discuss their importance for current practice in clinical and related settings, and outline briefly how they are influencing research into the causes of and possible future treatments for this prevalent disorder. Ann Neurol 2006;60:389–398</p></abstract><textClass><keywords scheme="Journal Subject"><list><head>article category</head><item><term>Neurological Progress</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="2006-04-21">Received</change><change when="2006-09-21">Registration</change><change when="2006-10">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><original>false</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/6FDB66D127E121559A4DA0D9AB3ACBE00279F873/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName><publisherLoc>Hoboken</publisherLoc></publisherInfo><doi registered="yes">10.1002/(ISSN)1531-8249</doi><issn type="print">0364-5134</issn><issn type="electronic">1531-8249</issn><idGroup><id type="product" value="ANA"></id></idGroup><titleGroup><title type="main" xml:lang="en" sort="ANNALS OF NEUROLOGY">Annals of Neurology</title><title type="short">Ann Neurol.</title></titleGroup></publicationMeta><publicationMeta level="part" position="40"><doi origin="wiley" registered="yes">10.1002/ana.v60:4</doi><numberingGroup><numbering type="journalVolume" number="60">60</numbering><numbering type="journalIssue">4</numbering></numberingGroup><coverDate startDate="2006-10">October 2006</coverDate></publicationMeta><publicationMeta level="unit" type="miscellaneous" position="50" status="forIssue"><doi origin="wiley" registered="yes">10.1002/ana.21022</doi><idGroup><id type="unit" value="ANA21022"></id></idGroup><countGroup><count type="pageTotal" number="10"></count></countGroup><titleGroup><title type="articleCategory">Neurological Progress</title><title type="tocHeading1">Neurological Progress</title></titleGroup><copyright ownership="thirdParty">Copyright © 2006 American Neurological Association</copyright><eventGroup><event type="manuscriptReceived" date="2006-04-21"></event><event type="manuscriptRevised" date="2006-09-15"></event><event type="manuscriptAccepted" date="2006-09-21"></event><event type="firstOnline" date="2006-10-26"></event><event type="publishedOnlineFinalForm" date="2006-10-26"></event><event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.3.25 mode:FullText source:FullText result:FullText" date="2010-11-10"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-01-03"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-14"></event></eventGroup><numberingGroup><numbering type="pageFirst">389</numbering><numbering type="pageLast">398</numbering></numberingGroup><correspondenceTo>Laboratory of Neurogenetics, National Institute on Aging, Porter Neuroscience Building, 35 Convent Drive, Bethesda, MD 20892</correspondenceTo><objectNameGroup><objectName elementName="figure">Illustration</objectName></objectNameGroup><linkGroup><link type="toTypesetVersion" href="file:ANA.ANA21022.pdf"></link></linkGroup></publicationMeta><contentMeta><countGroup><count type="figureTotal" number="1"></count><count type="tableTotal" number="1"></count><count type="referenceTotal" number="86"></count><count type="wordTotal" number="8471"></count></countGroup><titleGroup><title type="main" xml:lang="en">Genetics of Parkinson's disease and parkinsonism</title><title type="short" xml:lang="en">Genetics of PD and Parkinsonism</title></titleGroup><creators><creator xml:id="au1" creatorRole="author" affiliationRef="#af1" corresponding="yes"><personName><givenNames>John</givenNames><familyName>Hardy</familyName><degrees>PhD</degrees></personName><contactDetails><email>hardyj@mail.nih.gov</email></contactDetails></creator><creator xml:id="au2" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Huaiban</givenNames><familyName>Cai</familyName><degrees>PhD</degrees></personName></creator><creator xml:id="au3" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Mark R.</givenNames><familyName>Cookson</familyName><degrees>PhD</degrees></personName></creator><creator xml:id="au4" creatorRole="author" affiliationRef="#af2"><personName><givenNames>Katrina</givenNames><familyName>Gwinn‐Hardy</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au5" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Andrew</givenNames><familyName>Singleton</familyName><degrees>PhD</degrees></personName></creator></creators><affiliationGroup><affiliation xml:id="af1" countryCode="US" type="organization"><unparsedAffiliation>Laboratory of Neurogenetics, National Institute on Aging, National Institutes on Health, Bethesda, MD</unparsedAffiliation></affiliation><affiliation xml:id="af2" countryCode="US" type="organization"><unparsedAffiliation>National Institute of Neurological Diseases and Stroke, National Institutes of Health, Bethesda, MD</unparsedAffiliation></affiliation></affiliationGroup><fundingInfo><fundingAgency>Intramural Research Program of the NIH (National Institute on Aging)</fundingAgency></fundingInfo><abstractGroup><abstract type="main" xml:lang="en"><title type="main">Abstract</title><p>Until 10 years ago, conventional wisdom held that Parkinson's disease was not a genetic disorder. Since that time, there have been a plethora of genetic findings, culminating in the cloning of several genes that derive from the loci given the nomenclature PARK1‐PARK12 (OMIM 168600). Recently, these research findings have begun to impact clinical practice, and this impact is likely to increase. The primary purpose of this article is to outline these genetic advances, discuss their importance for current practice in clinical and related settings, and outline briefly how they are influencing research into the causes of and possible future treatments for this prevalent disorder. Ann Neurol 2006;60:389–398</p></abstract></abstractGroup></contentMeta></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Genetics of Parkinson's disease and parkinsonism</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>Genetics of PD and Parkinsonism</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Genetics of Parkinson's disease and parkinsonism</title></titleInfo><name type="personal"><namePart type="given">John</namePart><namePart type="family">Hardy</namePart><namePart type="termsOfAddress">PhD</namePart><affiliation>Laboratory of Neurogenetics, National Institute on Aging, National Institutes on Health, Bethesda, MD</affiliation><description>Correspondence: Laboratory of Neurogenetics, National Institute on Aging, Porter Neuroscience Building, 35 Convent Drive, Bethesda, MD 20892</description><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Huaiban</namePart><namePart type="family">Cai</namePart><namePart type="termsOfAddress">PhD</namePart><affiliation>Laboratory of Neurogenetics, National Institute on Aging, National Institutes on Health, Bethesda, MD</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Mark R.</namePart><namePart type="family">Cookson</namePart><namePart type="termsOfAddress">PhD</namePart><affiliation>Laboratory of Neurogenetics, National Institute on Aging, National Institutes on Health, Bethesda, MD</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Katrina</namePart><namePart type="family">Gwinn‐Hardy</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>National Institute of Neurological Diseases and Stroke, National Institutes of Health, Bethesda, MD</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Andrew</namePart><namePart type="family">Singleton</namePart><namePart type="termsOfAddress">PhD</namePart><affiliation>Laboratory of Neurogenetics, National Institute on Aging, National Institutes on Health, Bethesda, MD</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="other" displayLabel="miscellaneous"></genre><originInfo><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><place><placeTerm type="text">Hoboken</placeTerm></place><dateIssued encoding="w3cdtf">2006-10</dateIssued><dateCaptured encoding="w3cdtf">2006-04-21</dateCaptured><dateValid encoding="w3cdtf">2006-09-21</dateValid><copyrightDate encoding="w3cdtf">2006</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType><extent unit="figures">1</extent><extent unit="tables">1</extent><extent unit="references">86</extent><extent unit="words">8471</extent></physicalDescription><abstract lang="en">Until 10 years ago, conventional wisdom held that Parkinson's disease was not a genetic disorder. Since that time, there have been a plethora of genetic findings, culminating in the cloning of several genes that derive from the loci given the nomenclature PARK1‐PARK12 (OMIM 168600). Recently, these research findings have begun to impact clinical practice, and this impact is likely to increase. The primary purpose of this article is to outline these genetic advances, discuss their importance for current practice in clinical and related settings, and outline briefly how they are influencing research into the causes of and possible future treatments for this prevalent disorder. Ann Neurol 2006;60:389–398</abstract><note type="funding">Intramural Research Program of the NIH (National Institute on Aging)</note><relatedItem type="host"><titleInfo><title>Annals of Neurology</title></titleInfo><titleInfo type="abbreviated"><title>Ann Neurol.</title></titleInfo><genre type="Journal">journal</genre><subject><genre>article category</genre><topic>Neurological Progress</topic></subject><identifier type="ISSN">0364-5134</identifier><identifier type="eISSN">1531-8249</identifier><identifier type="DOI">10.1002/(ISSN)1531-8249</identifier><identifier type="PublisherID">ANA</identifier><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>60</number></detail><detail type="issue"><caption>no.</caption><number>4</number></detail><extent unit="pages"><start>389</start><end>398</end><total>10</total></extent></part></relatedItem><identifier type="istex">6FDB66D127E121559A4DA0D9AB3ACBE00279F873</identifier><identifier type="DOI">10.1002/ana.21022</identifier><identifier type="ArticleID">ANA21022</identifier><accessCondition type="use and reproduction" contentType="copyright">Copyright © 2006 American Neurological Association</accessCondition><recordInfo><recordContentSource>WILEY</recordContentSource><recordOrigin>Wiley Subscription Services, Inc., A Wiley Company</recordOrigin></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001D61 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001D61 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= ISTEX:6FDB66D127E121559A4DA0D9AB3ACBE00279F873
|texte= Genetics of Parkinson's disease and parkinsonism
}}
| This area was generated with Dilib version V0.6.23. |  |